Severe adverse reaction during treatment with rifampicin
Ebrid, B.; Ariño, M.D.; Cabeza, F.; Sebastián, A.
Revista Clinica Espanola 191(4): 231-232
1992
ISSN/ISBN: 0014-2565 PMID: 1439053 Document Number: 389081
Document emailed within 1 workday
Related Documents
Nakagawa, H.; Umene, Z.; Sunahara, S. 1981: Increased desacetylation of rifampicin and an adverse reaction Kekkaku: 56(12): 577-586Riska, N.; Mattson, K. 1972: Adverse reactions during rifampicin treatment Scandinavian Journal of Respiratory Diseases 53(2): 87-96
Shuster, M.; Do, D.; Nambudiri, V. 2015: Severe cutaneous adverse reaction to telaprevir Dermatology Online Journal 21(1)
Lysack, J.T.; Lysack, C.L.; Kvern, B.L. 1998: A severe adverse reaction to mefloquine and chloroquine prophylaxis Australian Family Physician 27(12): 1119-1120
Zeană, C.; Bănică, D.; Algeorge, G. 1981: Immunological aspects of adverse reactions during treatment with rifampicin Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 30(1): 33-37
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Shastri, V.; Betkerur, J.; Kushalappa, P.A.; Savita, T.G.; Parthasarathi, G. 2006: Severe cutaneous adverse drug reaction to leflunomide: a report of five cases Indian Journal of Dermatology Venereology and Leprology 72(4): 286-289
Lee, H.Y.; Ariyasinghe, J.T.; Thirumoorthy, T. 2008: Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Singapore Medical Journal 49(5): 384-387
Schiavino, D.; Murzilli, F.; Del Ninno, M.; Buonomo, A.; Roncallo, C.; Pollastrini, E.; De Pasquale, T.; Lombardo, C.; Nucera, E.; Patriarca, G. 2003: Demonstration of an IgE-mediated immunological pathogenesis of a severe adverse reaction to gadopentetate dimeglumine Journal of Investigational Allergology and Clinical Immunology 13(2): 140-142
Woo, J.; Chan, C.; Chan, R.; Cheung, W.; Or, K.; Chan, K. 1995: Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters Journal of Medicine 26(5-6): 279-294
De Lorenzo-Cáceres Ascanio, A.; Hernández-Mora, P.G.; Brezmes Valdivieso, J.A.; Serrallé Arias de Castro, J.R. 1987: Intense symptomatic bradycardia caused by sinoauricular block: severe adverse reaction caused by propafenone Medicina Clinica 89(11): 485-486
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Marasca, C.; Annunziata, M.Carmela.; Villani, A.; Volpe, S.; Marasca, D.; Fabbrocini, G. 2019: Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study Journal of Drugs in Dermatology: Jdd 18(5): 437-438
Rosen, B.L.; Brodkin, R.H. 1986: Isotretinoin in the treatment of steatocystoma multiplex: a possible adverse reaction Cutis 37(2): 115 120
Bravo, M.L.; Azagra, R.; Aguyé, A.; Freixas, M. 1992: Acute hepatitis: an adverse reaction to fenofibrate treatment Atencion Primaria 10(3): 697-698
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Saltoglu, N.; Tasova, Y.; Inal, A.S.; Seki, T.; Aksu, H.S. 2002: Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis Saudi Medical Journal 23(8): 921-924
Reimers, D. 1971: Malformations caused by rifampicin? 2 cases of normal fetal development after rifampicin treatment in early pregnancy Münchener Medizinische Wochenschrift 113(50): 1690-1691
Eskilsson, J.; Albertsson, M. 1988: Severe adverse cardiac effects during treatment with cisplatin and 5-fluorouracil Lakartidningen 85(35): 2734-2735
Shimizu, T.; Saijo, N. 2003: Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 61(6): 937-942